Search

Nov 5, 2024
BIO-Europe: Pareto Securities' Biotech Analyst Dan Akschuti shares his thoughts on the conference and discusses recent company successes in the nordic region
He says there has been an upswing in investors looking at companies. Plus, his thoughts on BioInvent, Oculis, and Camurus. Brought to you by

Sep 19, 2024
Pareto Securities' biotech analyst Dan Akschuti gives an overview of the 15th Annual Healthcare Conference and highlights companies in the region
He introduces us to Pareto and the conference, and highlights BioInvent, Oculis, Camurus, Vicore Pharma, and Calliditas.